Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Oral combination approaches with VX-950, VX-497 for HCV treatment; VX-950 comparable to BILN-2061

May 27, 2004

Rigel initiates phase I/II trial for R-803 in HCV

May 26, 2004

New European phase III trial for Zadaxin triple therapy in HCV

May 26, 2004

Efficacy and safety of tacrolimus in fistulizing Crohn's disease

May 26, 2004

Immunological changes induced by glatiramer acetate in an experimental colitis model

May 25, 2004

Alvimopan improves gastrointestinal transit in POI and chronic constipation

May 25, 2004

Prostaglandins suggested as a potential target in ulcerative colitis

May 25, 2004

Therapeutic benefits of adalimumab in Crohn's disease

May 24, 2004

Potential benefits of SLV-317 in irritable bowel syndrome

May 24, 2004

SciClone meets enrollment objective in phase III hepatitis C trial

May 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...